🔗 Visit the ClinicalTrials.gov page for NCT00170950
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. | N Engl J Med | 2008 | 11.61 |
| 2 | Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. | Lancet | 2012 | 6.69 |
| 3 | Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. | Lancet | 2010 | 3.16 |
| 4 | Cardiovascular events during differing hypertension therapies in patients with diabetes. | J Am Coll Cardiol | 2010 | 2.43 |
| 5 | Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. | Diabetes Metab Syndr Obes | 2014 | 1.05 |